SUBSCRIBE
SUBSCRIBE

CAR-T

Drug Development
Keep calm and CAR-T on?
Lori, Greg and Tyler discuss last week’s ⁠call for a class-wide box warning⁠ on all commercial CAR T therapies, while investigations are ongoing into ⁠cases of secondary malignancies⁠. How do we approach this ⁠balancing act⁠ of treatment and side effects?
January 31, 2024
 · 
1 min read
 · 
Lori Ellis
Load More
PRESS RELEASES
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
 · 
3 min read
Press Releases
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
March 24, 2025
 · 
9 min read
Press Releases
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
March 20, 2025
 · 
4 min read
Press Releases
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
March 19, 2025
 · 
7 min read
Press Releases
CARsgen Announced 2024 Annual Results
March 19, 2025
 · 
9 min read
Press Releases
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
March 14, 2025
 · 
19 min read
Press Releases
Luminary Therapeutics to Develop Allogeneic CAR T Therapy for Targeting Solid Tumors
March 11, 2025
 · 
2 min read
Press Releases
Bioheng Therapeutics Announces FDA Clearance of IND Application for CD7 UCAR T Cell Therapy in T-ALL/LBL
March 5, 2025
 · 
2 min read
Press Releases
Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
March 4, 2025
 · 
2 min read
Press Releases
IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
March 4, 2025
 · 
8 min read
Press Releases
CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
March 2, 2025
 · 
3 min read
Press Releases
CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease
February 27, 2025
 · 
3 min read
Press Releases
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
February 27, 2025
 · 
3 min read
Press Releases
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
February 26, 2025
 · 
4 min read
Press Releases
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
February 25, 2025
 · 
3 min read
Press Releases
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
February 24, 2025
 · 
4 min read
Press Releases
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
February 24, 2025
 · 
4 min read
Press Releases
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
February 18, 2025
 · 
4 min read
Press Releases
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
February 14, 2025
 · 
4 min read
Press Releases
Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla™ presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring
February 14, 2025
 · 
3 min read
Load More